Vacuna recombinante frente al virus de la septicemia hemorrágica vírica

摘要

The invention relates to a recombinant deoxyribonucleic acid vaccine comprising the sequence that codes for the ectodomain of the G glycoprotein of the viral hemorrhagic septicemia virus (VHSV), the sequence that codes for a signal peptide of the pleurocidin of Limanda limanda and carp &bgr;-actin promoter for the treatment and/or prevention of viral hemorrhagic septicemia caused by VHSV. The vaccine of the invention provides protection both by intramuscular administration and intraperitoneal administration.